Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 183,92
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
EUR 170,17
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Ruixiao LuDr. Ruixiao Lu is a recognized leader in the biotech and biopharma industry, currently serving as Vice President, Head of Biostatistics & Statistical Programming at Alumis Inc. She has held senior leadership roles at various c.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 251,43
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 480 pages. 9.18x6.12x9.45 inches. In Stock.
Sprache: Englisch
Verlag: Taylor & Francis Ltd Mai 2026, 2026
ISBN 10: 103254452X ISBN 13: 9781032544526
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Drug development is at a crossroads. As personalized medicine and targeted therapies expand, traditional clinical trial models have become too slow, costly, and inefficient. To meet the urgent need for faster, reliable evidence generation and decision making, researchers and regulators alike have turned to innovative trial designs. Among these, master protocols stand out as a transformative approach, allowing multiple therapies, disease subtypes, or objectives to be studied under a single, integrated framework. Proven successful in oncology, COVID-19, and beyond, they improve efficiency, reduce participant exposure to ineffective treatments, and accelerate meaningful outcomes with patient centric approach, prompting regulatory guidance and global adoption.This book provides a multidisciplinary exploration of master protocol clinical trials, blending clinical, statistical, regulatory, operational, economic insights and patients perspectives. It examines both opportunities and challenges in design and implementation, and provides in-depth summary and discussion on real-world examples such as I-SPY, ROAR, and RECOVERY. A practical guide for researchers, statisticians, regulators, and industry professionals, it demonstrates how master protocols can reshape drug development and bring innovative therapies to patients faster.¿ Provides comprehensive, theoretical and practical aspects for master protocol trials¿ Includes most recent development in the master protocol clinical trials¿ Covers broad topics such as trial designs, governance oversight, software implementation, database and data pipeline, multi-regional trials, risk and benefit with operational solutions, economic considerations, regulatory perspectives, patient engagement and diversity¿ Deep dives into numerous real world case studies, their underlying thinking, challenges and success.¿ Includes global perspective in multi-regional clinical development.